|
[1] LOPINA N, DYAGIL I, HAMOV D, et al. Case report of acute toxic imatinib-induced hepatitis in a patient with chronic myeloid leukemia, sulfa allergy, and rheumatoid arthritis[J]. Cureus, 2018, 10 (8) :e3136.
|
|
[2] BHATTY O, SELIM M, KASSIM T, et al. A case of imatinibinduced hepatitis[J]. Cureus, 2017, 9 (6) :e1302.
|
|
[3] ARNDTZ K, HIRSCHFIELD GM. The Pathogenesis of autoimmune liver disease[J]. Dig Dis, 2016, 34 (4) :327-333.
|
|
[4] LLEO A, MARZORATI S, ANAYA JM, et al. Primary biliary cholangitis:A comprehensive overview[J]. Hepatol Int, 2017, 11 (6) :485-499.
|
|
[5] LIASKOU E, HIRSCHFIELD GM, GERSHWIN ME. Mechanisms of tissue injury in autoimmune liver diseases[J]. Semin Immunopathol, 2014, 36 (5) :553-568.
|
|
[6] SELMI C, GERSHWIN ME. Chronic autoimmune epithelitis in Sjogren's syndrome and primary biliary cholangitis:A comprehensive review[J]. Rheumatol Ther, 2017, 4 (2) :263-279.
|
|
[7] IMAM MH, TALWALKAR JA, LINDOR KD. Clinical management of autoimmune biliary diseases[J]. J Autoimmun, 2013, 46:88-96.
|
|
[8] ZHANG LL, FAN YJ, TAN B, et al. Recognition of the clinical application and biological mechanism of ursodeoxycholic acid in liver disease[J]. Chin J Clin Pharmacol Ther, 2017, 22 (2) :233-240. (in Chinese) 张林林, 樊玉娟, 谭波, 等.熊脱氧胆酸在慢性肝病中应用及机制的再认识[J].中国临床药理学与治疗学, 2017, 22 (2) :233-240.
|
|
[9] NACIF LS, WAISBERG DR, PINHEIRO RS, et al.Imatinib-induced fulminant liver failure in chronic myeloid leukemia:Role of liver transplant and second-generation tyrosine kinase inhibitors:A case report[J]. J Med Case Rep, 2018, 12 (1) :63.
|
|
[10] DHALLUIN-VENIER V, BESSON C, DIMET S, et al. Imatinib mesylate-induced acute hepatitis with autoimmune features[J]. Eur J Gastroenterol Hepatol, 2006, 18 (11) :1235-1237.
|
|
[11] AL SOBHI E, ZAHRANI Z, ZEVALLOS E, et al. Imatinib-induced immune hepatitis:Case report and literature review[J]. Hematology, 2007, 12 (1) :49-53.
|
|
[12] GUNNARSSON N, HOGLUND M, STENKE L, et al. Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia[J]. Leukemia, 2016, 30 (7) :1562-1567.
|
DownLoad: